Search JIM Advanced Search

Journal of Chinese Integrative Medicine ›› 2009, Vol. 7 ›› Issue (3): 205-211.doi: 10.3736/jcim20090302

Special Issue: Traditional Chinese Medicine

• Original Clinical Research • Previous Articles     Next Articles

Correlation between cognitive functions and syndromes of traditional Chinese medicine in amnestic mild cognitive impairment

 Ying-chun Miaoa, Jin-zhou Tiana, Jing Shia, Min Maoa, Xiao-dong Zhaoa, Li-yan Fangb, Chui-you Zenga, Jian-ping Liuc, Zhi-liang Wangd, Xiao-bin Lid   

  1. a Department of Geriatric Disease, Dongzhimen Hospital, Beijing University of Chinese Medcine, Beijing 100700, China
    b Department of Traditional Chinese Medicine, China Rehabilitation Research Center, Beijing Boai Hospital, Beijing 100068, China
    c Center for Evidence-Based Medicine,Beijing University of Chinese Medicine, Beijing 100029, China
    d North China Pharmaceutical Group Formulation Company Limited, Shijiazhuang 050015, Hebei Province, China
  • Received:2008-09-11 Accepted:2008-12-08 Online:2009-03-20 Published:2009-03-15

Objective

To explore the correlation between the cognitive functions and syndromes of traditional Chinese medicine (TCM) in amnestic mild cognitive impairment (aMCI), and to provide evidence for clinical syndrome differentiation treatment.
Methods

Six hundred subjects from Dongzhimen Hospital and seven communities in Beijing, aged between 40 and 85 years, accepted neuropsychological assessments, imaging and biochemical examinations, and syndrome differentiation, from whom 159 aMCI patients, 213 normal control (NC) subjects and 171 Alzheimer’s dementia (AD) patients were screened out. Correlation between the cognitive functions and TCM syndromes in aMCI patients was analyzed.
Results

Mini-Mental State Examination (MMSE) score in aMCI patients was closely correlated with kidney essence vacuity and deficiency of blood and qi (r=–0.11, r=–0.11; P=0.003, P=0.015). Delayed Word Recall (DWR) score was correlated with kidney essence vacuity (r=–0.20, P=0.020). Instant Story Recall (ISR) and Delayed Story Recall (DSR) scores were respectively correlated with turbid phlegm blocking upper orifices (r=–0.11, r=–0.27; P=0.021, P=0.000). Language function was correlated with kidney essence vacuity and deficiency of blood and qi (r=–0.11, r=–0.13; P=0.042, P=0.007). Attention/calculation was also closely correlated with kidney essence vacuity and deficiency of blood and qi (r=–0.10, r=–0.21; P=0.039, P=0.010). Attention score of aMCI patients was correlated with excess of heat toxin syndrome (r=–0.29, P=0.026).
Conclusion

The memory decline of aMCI is correlated with kidney essence vacuity and turbid phlegm blocking upper orifices. Furthermore, turbid phlegm blocking upper orifices is correlated with episodic memory decline, which is closely related to AD. The aMCI patients with phlegm have the risk to progress into AD. Although other cognitive functions of aMCI remain relatively intact, the patients’ language function, attention/calculation and the whole cognitive function may be worsen as the aggravation of kidney essence vacuity, deficiency of blood and qi, phlegm and heat toxin, and may eventually lead to multiple cognitive domains impairment, even dementia.

Key words: Amnestic mild cognitive impairment, Cognitive functions, Syndromes in traditional Chinese modicion, Corrolation

"

Syndrome TCM syndrome score
NC group (n=213) aMCI group (n=159) AD group (n=171)
Kidney essence vacuity 10.60±3.24 11.61±2.65* 12.78±3.40**
Turbid phlegm blocking upper orifices 10.18±3.35 11.94±2.90** 12.23±3.18**
Blood stasis obstructing brain collaterals 8.95±1.93 9.88±2.73* 10.30±1.94*
Hyperactivity of yang due to yin deficiency 9.88±2.73 9.22±2.34 9.96±2.42
Deficiency of blood and qi 8.67±1.63 9.55±2.68 8.92±2.51
Excess of heat toxin 9.41±3.70 9.50±3.31 9.14±2.91
Viscera stagnation and turbid left 9.14±2.91 9.40±3.06 10.43±2.87

"

Syndrome n Correlation coefficient
MMSE ISR DSR MoCA HVLT CDT
Kidney essence vacuity 159 –0.11** –0.14 –0.06 –0.08 –0.19 0.02
Turbid phlegm blocking upper orifices 159 –0.06 –0.11* –0.27** 0.23 0.03 –0.01
Blood stasis obstructing brain collaterals 159 –0.01 –0.10 –0.05 –0.01 –0.12 –0.11
Hyperactivity of yang due to yin deficiency 159 0.19 –0.02 0.03 –0.20 –0.03 0.03
Deficiency of blood and qi 159 –0.04* –0.09 –0.03 –0.05 –0.10 0.07
Excess of heat toxin 159 –0.02 –0.02 –0.10 –0.04 –0.09 0.11
Viscera stagnation and turbid left 159 –0.11 –0.01 –0.10 –0.13 –0.03 –0.08

"

Syndrome n Correlation coefficient
IWR (MMSE) DWR (MMSE) DWR (MoCA) HVLT
TKidney essence vacuity 159 –0.09 –0.10 –0.20* –0.19
Turbid phlegm blocking upper orifices 159 0.01 –0.08 0.10 0.03
Blood stasis obstructing brain collaterals 159 0.07 –0.02 –0.18 –0.12
Hyperactivity of yang due to yin deficiency 159 –0.02 0.09 –0.24 –0.03
Deficiency of blood and qi 159 0.02 –0.04 –0.13 –0.10
Excess of heat toxin 159 0.03 0.02 –0.14 –0.09
Viscera stagnation and turbid left 159 0.05 –0.12 –0.03 –0.03

"

Syndrome Correlation coefficient
n ISR DSR
Kidney essence vacuity 159 –0.14 –0.06
Turbid phlegm blocking upper orifices 159 –0.11* –0.27**
Blood stasis obstructing brain collaterals 159 –0.10 –0.05
Hyperactivity of yang due to yin deficiency 159 –0.02 0.03
Deficiency of blood and qi 159 0.09 –0.03
Excess of heat toxin 159 –0.02 –0.10
Viscera stagnation and turbid left 159 –0.01 –0.10

"

Cognitive function Correlation coefficient
Kidney
essence vacuity
Turbid phlegm
blocking upper
orifices
Blood stasis
obstructing
brain collaterals
Hyperactivity
of yang due to
yin deficiency
Deficiency of
blood and qi
Excess of
heat toxin
Viscera
stagnation and
turbid left
Language
MMSE –0.11* –0.02 0.11 0.10 –0.13** –0.04 0.11
MoCA –0.06 0.21 0.13 –0.08 –0.06 –0.13 –0.05
Attention/calculation
MMSE –0.10* 0.01 0.03 0.03 –0.21* 0.02 –0.09
MoCA –0.09 0.22 0.09 –0.10 –0.19 –0.29* –0.09
Abstraction
MoCA 0.14 0.01 0.03 0.08 –0.04 0.03 –0.02
Visuospatial and executive function
MoCA 0.02 0.08 0.13 –0.15 –0.06 –0.08 –0.07
CDT 0.02 –0.01 –0.11 0.03 –0.08 0.07 0.11
Orientation
Time –0.12 0.03 0.02 0.15 –0.05 –0.02 0.07
Place 0.03 0.11 0.01 –0.03 0.01 –0.13 –0.08
Total 0.08 0.08 0.05 0.07 –0.06 0.13 –0.01
[1] Petersen RC . Mild cognitive impairment: transition between aging and Alzheimer's disease[J]. Neurologia, 2000,15(3):93-101
[2] Ritchie K, Touchon J . Mild cognitive impairment: conceptual basis and current nosological status[J]. Lancet, 2000,355(9199):225-228
doi: 10.1016/S0140-6736(99)06155-3
[3] Hanninen T, Hallikainen M, Tuomainen S, Vanhanen M, Soininen H . Prevalence of mildcognitive impair-ment: a population-based study in elderly subjects[J]. Acta Neurol Scand, 2002,106(3):148-154
[4] Petersen RC, Smith GE, Waring SC, Ivnik RJ, Tangalos EG, Kokmen E . Mild cognitive impairment: clinical characterization and outcome[J]. Arch Nerol, 1999,56(3):303-308
doi: 10.1001/archneur.56.3.303
[5] Busse A, Bischkopf J, Riedel-Heller SG, Angermeyer MC . Subclassifications for mild cognitive impairment: prevalence and predictive validity[J]. Psychol Med, 2003,33(6):1029-1038
doi: 10.1017/S0033291703007839
[6] Petersen RC, Thomas RG, Grundman M, Bennett D, Doody R, Ferris S, Galasko D, Jin S, Kaye J, Levey A, Pfeifer E, Sano M, van Dyck CH, Thal LJ; Alzheimer’s Disease Cooperative Study Group .Vitamin E and donepezil for the treatment of mild cognitive impairment[J]. N Engl J Med, 2005,352(23):2379-2388
doi: 10.1056/NEJMoa050151
[7] Clinical trial: Institute on Aging. Memory impairment study (mild cognitive impairment study)[2007-05-24]. .
[8] Clinical trial: Nicotine treatment of mild cognitive impairment[2007-05-24]. .
[9] McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM . Clinical diagnosis of Alzheimer’s disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer’s Disease[J]. Neurology, 1984,34(7):939-944
doi: 10.1212/WNL.34.7.939
[10] Tian JZ, Shi J, Zhang XQ, Bi Q, Ma X, Wang ZL, Li XB, Sheng SL, Li L, Wu ZY, Fang LY, Zhao XD, Miao YC, Wang PW, Ren Y, Yin JX, Wang YY . Guiding principles of clinical research on mild cognitive impairment(protocol)[J]. J Chin Integr Med, 2008,6(1):9-14
田金洲, 时晶, 张新卿, 毕齐, 马辛, 王志良, 李晓斌, 盛树力, 李林, 吴振云, 房立岩, 赵晓东, 苗迎春, 王蓬文, 任映, 尹军祥, 王永炎 . 轻度认知损害临床研究指导原则(草案)[J]. 中西医结合学报, 2008,6(1):9-14
[11] 11Howieson DB, Dame A, Camicioli R, Sexton G, Payami H, Kaye JA, Chen GZ . Cognitive signs of healthy elderly population preceding Alzheimer’s dementia[J]. Shi Jie Yi Xue Za Zhi, 1998,2(3):24-28
Howieson DB, Dame A, Camicioli R, Sexton G, Payami H, Kaye JA, 陈国璋 .健康老年人阿耳茨海默痴呆前的认识标记[J]. 世界医学杂志, 1998,2(3):24-28
[12] Aggarwal NT, Wilson RS, Beck TL, Bienias JL, Bennett DA . Mild cognitive impairment in different functional domains and incident Alzheimer’s disease[J]. J Neurol Neurosurg Psychiatry, 2005,76(11):1479-1484
doi: 10.1136/jnnp.2004.053561
[13] Tian JZ, Yang CZ, Sheng T, Liu H . The correlation of characters of cognitive impairment preceding Alzheimer’s dementia in individuals with questionable dementia to Chinese medical syndrome[J]. Hubei Zhong Yi Xue Yuan Xue Bao, 1999,1(4):49-54
田金洲, 杨承芝, 盛彤, 刘桓 . 可疑痴呆人群中阿尔茨海默病临床前的认知损害特征及其与中医证候关系[J]. 湖北中医学院学报, 1999,1(4):49-54
[14] Kuller LH, Shemanski L, Manolio T, Haan M, Fried L, Bryan N, Burke GL, Tracy R, Bhadelia R . Relationship between ApoE, MRI findings and cognitive function in the Cardiovascular Health Study[J]. Stroke, 1998,29(2):40-46
doi: 10.1161/01.STR.29.1.40
[15] Wehr H, Parnowski T, Puzyński S, Bednarska-Makaruk M, Bisko M, Kotapka-Minc S, Rodo M, Wolkowska M . Apolipoprotein E genotype and lipid and lipoprotein levels in dementia[J]. Dememt Geratr Cogn Disord, 2000,11(2):70-73
doi: 10.1159/000017217
[16] Sheng SL. Alzheimer’s disease: from molecular biology to clinical diagnosis and treatment[M]. Beijing: Scientific and Technical Documents Publishing House,1998: 128-138
盛树力 . 老年性痴呆: 从分子生物学到临床诊治(北京)[M]. 北京: 科学技术文献出版社, 1998,( 北京):128-138
No related articles found!
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
[1] Jin-rong Fu. Establishment of multivariate diagnosis and treatment system of modern gynecology of traditional Chinese medicine. Journal of Chinese Integrative Medicine, 2008, 6(1): 22-24
[2] Hao Li, Ming-jiang Yao, Wen-ming Zhao, Jie Guan, Lin-lin Cai, Ling Cui. A randomized, controlled, double-blind trial of Huannao Yicong capsule in senile patients with mild cognitive impairment. Journal of Chinese Integrative Medicine, 2008, 6(1): 25-31
[3] Zhi-chun Jin. Problems in establishing clinical guideline for integrated traditional Chinese and Western medicine. Journal of Chinese Integrative Medicine, 2008, 6(1): 5-8
[4] SUN Ming-yu, ZUO Jian, DUAN Ji-feng, HAN Jun, FAN Shi-ming, ZHANG Wei, ZHU Li-fang, YAO Ming-hui. Antitumor activities of kushen flavonoids in vivo and in vitro. Journal of Chinese Integrative Medicine, 2008, 6(1): 51-59
[5] Min Cheng, Qiong Feng, Shu-wen Qian, Hui Gao, Cui-qing Zhu. Preliminary assay of p-amyloid binding elements in heart-beneficial recipe. Journal of Chinese Integrative Medicine, 2008, 6(1): 68-72
[6] Ning-qun Wang, Liang-duo Jiang, Zong-xing Li. Research progress in asthma-related quality of life. Journal of Chinese Integrative Medicine, 2008, 6(1): 93-97
[7] Jing-yuan Mao, Chang-xiao Liu, Heng-he Wang, Guang-li Wei , Zhen-peng Zhang, Jie Xing, Wang Xian liang , Ying-fei Bi . Effects of Shenmai Injection on serum concentration and pharmacokinetics of digoxin in dogs with heart failure. Journal of Chinese Integrative Medicine, 2010, 8(11): 1070-1074
[8] Zhi-mei Wang, Bin Zhang. A study on translation of ellipses in Huangdi Neijing from perspective of hermeneutic theory. Journal of Chinese Integrative Medicine, 2010, 8(11): 1097-1100
[9] Gui Yu, Jie Wang. Thinking on building the network cardiovasology of Chinese medicine. Journal of Chinese Integrative Medicine, 2012, 10(11): 1206-1210
[10] Pedro Saganha João, Doenitz Christoph, Greten Tobias, Efferth Thomas, J. Greten Henry. Qigong therapy for physiotherapists suffering from burnout: a preliminary study. Journal of Chinese Integrative Medicine, 2012, 10(11): 1233-1239